English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/24423
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis

AuthorsGonzález-Navarro, Herminia ; Naim Abu Nabah, Yafa ; Vinué, Ángela ; Andrés-Manzano, María J.; Collado, Manuel; Serrano, Manuel; Andrés, Vicente
KeywordsARF
CDKN2A
atherosclerosis
apoptosis
macrophage
vascular smooth
muscle cell
Issue Date18-May-2010
PublisherElsevier
CitationJournal of the American College of Cardiology 55(20): 2258-2268 (2010)
AbstractOBJECTIVES: The goal of this study was to investigate the role in atherosclerosis of the tumor suppressor protein ARF (human p14(ARF), mouse p19(ARF)) encoded by the CDKN2A gene. BACKGROUND: Atherosclerosis is characterized by excessive proliferation and apoptosis, 2 cellular processes regulated by CDKN2A. Although recent genome-wide association studies have linked atherosclerotic diseases to a genomic region in human chromosome 9p21 near the CDKN2A locus, the mechanisms underlying this gene-disease association remain undefined, and no causal link has been established between CDKN2A and atherosclerosis. METHODS: Atherosclerosis-prone apolipoprotein E (apoE)-null and doubly deficient apoE-p19(ARF) mice were fed an atherogenic diet and sacrificed to quantify atherosclerosis burden in whole-mounted aortas and in aortic cross-sections. Proliferation and apoptosis were investigated in atherosclerotic lesions and in primary cultures of macrophages and vascular smooth muscle cells obtained from both groups of mice. RESULTS: Genetic disruption of p19(ARF) in apoE-null mice augments aortic atherosclerosis without affecting body weight, plasma lipoproteins, or plaque's proliferative activity. Notably, p19(ARF) deficiency significantly attenuates apoptosis both in atherosclerotic lesions and in cultured macrophages and vascular smooth muscle cells, 2 major cellular constituents of atheromatous plaques. CONCLUSIONS: Our findings establish a direct link between p19(ARF), plaque apoptosis, and atherosclerosis, and suggest that human genetic variants associated to diminished CDKN2A expression may accelerate atherosclerosis by limiting plaque apoptosis.
Description11 pages, 5 figures.-- PMID: 20381282 [PubMed]
Publisher version (URL)http://dx.doi.org/10.1016/j.jacc.2010.01.026
URIhttp://hdl.handle.net/10261/24423
DOI10.1016/j.jacc.2010.01.026
ISSN0735-1097
Appears in Collections:(IBV) Artículos
Files in This Item:
File Description SizeFormat 
JACC120409-5696D-revision 2.pdfArtículo Principal473,33 kBAdobe PDFThumbnail
View/Open
Online supplement-JACC120409-5696D.pdfOnline supplement114,13 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.